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Abstract: Trypanosoma cruzi, the etiologic agent of Chagas disease, cycles through different life
stages characterized by defined molecular traits associated with the proliferative or differentiation
state. In particular, T. cruzi epimastigotes are the replicative forms that colonize the intestine of
the Triatomine insect vector before entering the stationary phase that is crucial for differentiation
into metacyclic trypomastigotes, which are the infective forms of mammalian hosts. The transition
from proliferative exponential phase to quiescent stationary phase represents an important step
that recapitulates the early molecular events of metacyclogenesis, opening new possibilities for
understanding this process. In this study, we report a quantitative shotgun proteomic analysis of
the T. cruzi epimastigote in the exponential and stationary growth phases. More than 3000 proteins
were detected and quantified, highlighting the regulation of proteins involved in different subcellular
compartments. Ribosomal proteins were upregulated in the exponential phase, supporting the higher
replication rate of this growth phase. Autophagy-related proteins were upregulated in the stationary
growth phase, indicating the onset of the metacyclogenesis process. Moreover, this study reports the
regulation of N-terminally acetylated proteins during growth phase transitioning, adding a new layer
of regulation to this process. Taken together, this study reports a proteome-wide rewiring during
T. cruzi transit from the replicative exponential phase to the stationary growth phase, which is the
preparatory phase for differentiation.
Keywords: Trypanosoma cruzi; metacyclogenesis; exponential and stationary phases; quantitative
proteomics; Gim5a; N-acetyltransferases; protein N-terminal acetylation; autophagy
1. Introduction
Cell proliferation is controlled by a series of environmental factors such as temperature,
population density due to the presence of critical quantities of quorum-sensing molecules and specific
growth factors, osmolarity, pH, the redox state of the environment, and the availability of essential
nutrients [1,2]. Cells are usually able to sense all these factors and orchestrate a variety of responses.
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As a result, cells initially face a binary decision: proliferate or enter into a specialized non-dividing
resting state, known as stationary/quiescent phase or G0 [3]. For example, it is well demonstrated that
under a severe metabolic stress condition known as starvation, yeasts arrest their cell cycle and then
enter into a G0/quiescence state that promotes persistence and survival [3]. Usually, this change is
concomitant with deep modification of the cells’ structures that can yield resistance structures such as
cysts or spores [4,5]. Besides cell cycle arrest, other changes are observed during transitioning from
proliferating to the quiescent phase, such as changes in their mass and volume, transcription, mRNA
degradation, and translation, resulting in a different protein expression pattern. Additionally, the
autophagy process is frequently induced in the stationary phase [6]. As a result, quiescent cells become
more thermotolerant and osmotolerant than their proliferating counterparts [7].
Trypanosoma cruzi, the etiologic agent of Chagas disease, cycles through different life stages that
harbor intricate molecular features that are needed in order to survive into the alimentary tract of the
invertebrate vector, and the bloodstream and the intracellular environment of the vertebrate host [8].
In particular, epimastigote forms are replicative in the Triatominae insects, colonizing their digestive
tract. An active proliferation is needed for establishing the infection in the insect host, while entering in
the stationary phase is a condition for its survival and differentiation into metacyclic trypomastigotes,
which is the stage that is able to initiate the infectious process in mammals. Thus, a refined regulation
of the cell physiology in these states is a conditio sine qua non for the parasite to complete its natural
life cycle [9].
One of the most critical environmental factors affecting the proliferative/quiescent state of cells is
the availability of nutrients. In the case of T. cruzi epimastigotes, it was shown that the progressive
changes of nutrients availability in in vitro cultures lead initially to an adaptive metabolic switch
from a metabolism based on carbohydrates consumption to a metabolism based on amino acids
consumption [10,11]. Under metabolites exhaustion, T. cruzi epimastigotes undergo cell cycle arrest,
which is considered a trigger for its differentiation to metacyclic forms [12]. These forms are responsible
for infecting the vertebrate host, as shown by a seminal work from Camargo [13]. Due to that, T. cruzi
in the stationary phase could recapitulate the early molecular events of metacyclogenesis, and can be
considered as an onset for differentiation, opening new possibilities to understand the early events of
metacyclogenesis. Several efforts have been made to understand the molecular events underlining
this process. Parodi-Talice et al. used two-dimensional (2D) gels in combination with matrix-assisted
laser desorption/ionization-time-of-flight (MALDI-TOF) analysis to identify proteins involved in the
metacyclogenesis [14]. T. cruzi Dm28c strain epimastigotes were cultured in liver infusion tryptose
(LIT) and collected at the exponential phase. Subsequently, the cells were submitted to nutritional stress
in triatomine artificial urine (TAU) medium for 2 h before starting the differentiation using the TAU
medium supplemented with glucose, proline, glutamate and aspartate (TAU3AAG) for 3 h and 24 h.
Adherent differentiating epimastigotes were collected, and metacyclic trypomastigotes were purified.
Almost 50% of the detected protein spots were unique in the different conditions showing a global
proteome remodeling during metacyclogenesis. Forty-three proteins were identified and assigned
to antioxidant response, protein biosynthesis, and cytoskeleton organization. Interestingly, several
proteoforms displayed a differential modulation during metacyclogenesis, indicating the dysregulation
of post-translational modification processes. Another study from Godoy et al. applied quantitative
shotgun proteomics to dissect the metacyclogenesis process [15]. T. cruzi epimastigotes from the Dm28c
strain were initially cultured for 5 days in LIT medium, and then submitted to nutritional stress by
incubation in TAU medium. After 30 min and 2 h, the parasites were collected before being diluted
into TAU3AAG medium, and the adhered parasites were collected after 12 h [16,17]. Metacyclic
trypomastigotes were purified by diethylaminoethylcellulose (DEAE–cellulose) chromatography.
Quantitative shotgun proteomics analysis allowed the identification of proteins involved in this
process. The majority of changes were seen when comparing the metacyclic trypomastigotes with the
epimastigotes. Recently, Amorim et al. analyzed the phosphoproteome of the adherent population
of T. cruzi parasites during metacyclogenesis [18]. In particular, T. cruzi epimastigotes from the
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Dm28c strain were subjected to nutritional stress in TAU medium for 2 h, and then differentiated
into the metacyclic trypomastigotes from 6 h to 96 h. The phosphoproteome analysis revealed the
regulation of 260 phosphosites associated to a global modulation of kinases and phosphatases during
metacyclogenesis. Barisón et al. have studied the metabolic state of T. cruzi in the exponential and
stationary phases using a targeted metabolomics approach [11]. The metabolic shift from glucose to
amino acids consumption was shown in the stationary phase, demonstrating an adaptation of the
parasite to nutritional stress conditions.
In this work, we applied a comprehensive quantitative proteomics strategy based on high
resolution and accuracy mass spectrometry (MS) to identify the molecular events regulated during
transitioning from exponential to stationary growth phases in T. cruzi. More than 3000 proteins were
detected and quantified in the two phases covering several cellular compartments and biological
functions. In particular, ribosomal proteins were massively upregulated in the exponential phase,
while the calreticulin—the protein localized in the endoplasmic reticulum—was detected upregulated
in the stationary phase. The regulated proteins were associated to metabolic processes and membrane
transporters, indicating a proteome-wide rewiring during the transitioning between the two phases.
Metabolic proteins such as proline dehydrogenase and malate dehydrogenase were upregulated
in the stationary and exponential phases, respectively. Membrane proteins such as ADP/ATP
mitochondrial carrier protein was upregulated in the exponential phase, while amastin and Gim5 were
upregulated in the stationary phase. Interestingly, the uncharacterized proteins upregulated in the
stationary phase were enriched in the autophagy protein Apg6 domain. This domain is associated
to the autophagosome formation, which is an important process activated during metacyclogenesis.
On the contrary, the WD40 domain G-beta (Gβ) repeat was upregulated in the exponential phase
uncharacterized proteins and is associated with cell division and gene transcription. Moreover, this
study reports the regulation of N-terminally acetylated proteins during growth phase transitioning.
Taken together, the metabolic pressure induced by nutrient starvation remodels the proteome of T. cruzi
from the exponential to the stationary phase, revealing novel targets for early differentiation events.
2. Materials and Methods
2.1. Parasites and Sample Preparation
T. cruzi CL strain clone 14 epimastigotes [11,19,20] were grown in LIT medium supplemented
with 10% fetal calf serum (FCS) at 28 ◦C [13]. Exponential phase epimastigotes (Exp) were obtained
from a 24 h culture starting at 2.5 × 107 parasites/mL (Figure 1). Stationary phase epimastigotes (St)
were obtained from an exponential culture at 5.0 × 106 parasites/mL and maintained for four days
without media change. Parasites were harvested by centrifugation at 4000 rpm for 10 min and washed
twice with cold PBS (137 mM of NaCl, 2.7 mM of KCl, 10 mM of Na2HPO4, 1.8 mM of KH2PO4,
pH 7.4). The classification of the T. cruzi CL-14 strain was performed by gene sequencing [21]. It is
important to highlight that T. cruzi cells in the stationary phase were epimastigotes, since metacyclic
trypomastigotes started to appear later at seven days post-culture and constituted a minor portion
(less than 7%) of the total cells.
2.2. Protein Extraction and Digestion
The samples were separately resuspended in PBS extraction buffer containing 8 M of urea,
10 mM of dithiothreitol (DTT), benzonase, and a protease inhibitor cocktail (Sigma-Aldrich, St. Louis,
MO, USA). Protein concentrations were determined by the Qubit fluorimetric detection method.
The proteins were diluted in water to a concentration of 1 of nmol/µL, and reduced by the addition of
dithiothreitol (DTT) to a final concentration of 10 mM and incubation for 30 min. The proteins were
alkylated prior to digestion by the addition of iodoacetamide (IAA) to a final concentration of 40 mM,
and incubation for 30 min in the dark at room temperature. To quench the reaction, DTT was added to
a final concentration of 5 mM. Porcine trypsin (1:50, w/w) (Promega, Fitchburg, WI, USA) was added,
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and the mixture was incubated overnight at room temperature. The resulting peptide mixtures were
desalted with hydrophilic–lipophilic-balanced solid phase extraction (Waters) and peptides eluted
with 1 mL of 70% (v/v) acetonitrile and 1% (v/v) trifluoroacetic acid (TFA). Two biological replicates
and two technical replicates were acquired for each condition.
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Figure 1. Mass spectrometry-based proteomics approach to assess the regulation of proteins during
transitioning from exponential to stationary phase in Trypanosoma cruzi cells. (A) Proteomics
workflow for identification and quantification of regulated proteins in T. cruzi during growth phase
transitioning. T. cruzi epimastigote cells were taken during the exponential and stationary phase
before protein extraction and tryptic digestion. Tryptic peptides were analyzed by nano-liquid
chromatography tandem mass spectrometry (nLC-MS/MS) analysis. After data and bioinformatic
analysis combined with functional studies, this approach made possible the assessment of protein
regulation during T. cruzi exponential to stationary phase transitioning. (B) Epimastigotes growth curve
presenting typical exponential and stationary phases with physiological differences. Optic microscopy
representative images show the different shape of the exponential and stationary phases of the parasite.
(C) Microscopic analysis of T. cruzi epimastigotes at the exponential and stationary phases using
phase-contrast microscope and DAPI staining. DIC: differential interference contrast. Scale bar: 4 µm.
2.3. Mass Spectrometry-Based Analysis of T. cruzi Tryptic Peptides
The peptides were separated by nano-liquid chromatography tandem mass spectrometry
(nLC-MS/MS) on an EASY-Spray PepMap® 50 cm × 75 µm C18 Column using an Easy nLC1000
nanoflow system (Thermo Fisher Scientific, Waltham, MA, USA). The high-performance liquid
chromatography (HPLC) gradient was 5–25% solvent B (A 0.1% formic acid; B 100% acetonitrile (ACN),
0.1% formic acid) for 90 min at a flow of 300 nL/min. Mass spectrometric analysis was performed
using an Orbitrap Fusion Tribrid mass spectrometer (Thermo Fisher Scientific); the maximum total
cycle time was confined to 3 s. The most intense precursors selected from the FT MS1 full scan
(resolution 120,000 full width at half-maximum (FWHM) @ m/z 200) were quadrupole-isolated and
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fragmented by collision-induced dissociation (CID) and detected in the dual-pressure linear ion trap
with 30 as normalized collision energy. The MS1 scan range was between 380–1500 m/z, the ion
count target was set to 2 × 105, the MS2 ion count target was set to 1 × 104, and the max injection
time was 50 ms and 35 ms for MS1 and MS2, respectively. The dynamic exclusion duration was
set to 10 s with a 10-ppm tolerance around the selected precursor and its isotopes. Two liquid
chromatography tandem mass spectrometry (LC-MS/MS) experiments were performed for each
biological replicates of the two life cycle stages of T. cruzi. The mass spectrometry proteomics data
have been deposited to the ProteomeXchange Consortium via the PRIDE [22] partner repository with
the dataset identifier PXD010768.
2.4. Protein Identification and Quantification
LC-MS/MS raw files were imported into MaxQuant version 1.5.2.8 [23] for identification
and label-free quantification (LFQ) of proteins and peptides. MS/MS spectra were searched
against the combined Uniprot T. cruzi CL Brener (downloaded, February 2018; 19,244 entries) and
common contaminants protein database with a mass tolerance level of 4.5 ppm for MS and 0.5 Da
for MS/MS. Enzyme specificity was set to trypsin, with a maximum of two missed cleavages.
The carbamidomethylation of cysteine (57.0215 Da) was set as a fixed modification, and the oxidation
of methionine (15.9949 Da), deamidation NQ (+0.9840 Da), and protein N-terminal acetylation
(42.0105 Da) were selected as variable modifications. The minimum peptide length was set to
seven amino acid residues. The match between runs feature of MaxQuant, which enables peptide
identifications between samples based on their accurate mass and retention time, was applied with a
match time window of 0.7 min and an alignment time window of 20 min. All of the identifications
were filtered in order to achieve a protein false discovery rate (FDR) of 1% [24–26].
Proteins identified in the reverse database, and contaminants identified only by site were removed
before performing statistical analysis. The dependent peptide algorithm was activated.
Proteins were quantified based on non-modified and N-terminally acetylated peptides. Oxidized
and deamidated peptides were not considered for protein quantification, since these could have been
raised from chemical artefacts, affecting the accuracy of protein quantification. Proteins quantified in
two replicates of at least one biological condition were considered for further analyses. Proteins that
appeared in two biological replicates of one condition and were not identified in the other biological
replicate were considered exclusive proteins.
2.5. Bioinformatic Analysis
Statistical analyses of the proteome data were performed using Perseus v.1.5.1.6 [27]. To determine
proteins with significant changes in abundances, t-test analysis was applied with permutation-based
FDR correction at a FDR of 5%. Functional enrichment analysis was performed using Protein Center
software (Thermo Fisher). The mRNA levels of some proteins discussed in this manuscript were
retrieved from the TriTrypDB [28–30].
To evaluate the domains represented in the regulated uncharacterized proteins in the exponential and
stationary growth phases, a standalone RPS-BLAST (v2.2.31+) was performed using the uncharacterized
proteins in FASTA format as query, a dataset of position-specific scoring matrix (PSSM) [31] from CDD
(Conserved Domain Database) [32] as database and 1 × 10−5 as e-value threshold.
Sequence homology between human and T. cruzi N-α-acetyltransferases was analyzed using
BLASTP against T. cruzi strain CL Brener (taxid:353153) from the non-redundant database in NCBI [33].
2.6. Sequence Search and Phylogenetic Analysis
Two proteins detected in our MS/MS quantification analysis (a putative Nat1; accession number
Q4D4R3 (Tc00.1047053504163.110) and an uncharacterized protein with the WD40 domain; accession
number Q4DEL9 (Tc00.1047053507941.60) were used to perform phylogenetic analysis on T. cruzi
genetic subdivisions termed discrete typing units (DTUs), T. cruzi marinkellei, T. dionisii, T. erneyi,
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and T. rangeli. Orthologs of selected proteins were obtained in the available genomes (completed
and drafts) using a standalone tBLASTn (v2.2.31+). The genome from T. cruzi (JR cl. 4), T. cruzi
(Sylvio X10/1), T. cruzi (CL Brener), T. cruzi marinkellei (B7), T. cruzi (Esmeraldo), and T. rangeli (SC58)
are available in TriTrypDB (http://tritrypdb.org/tritrypdb/). T. cruzi (Tula cl2), T. cruzi (Bug2148),
T. cruzi (Y), and T. cruzi (231) genome drafts are available in NCBI-Genbank [33]. The genome drafts
from T. dionisii (TCC211), T. erneyi (TCC1946), T. rangeli (AM80), T. cruzi marinkellei (TCC344), T. cruzi
(G)(TCC874), and T. cruzi (M-6241 TCC 2123) have been generated in our laboratories within the
assembling the tree of life (ATOL, NSF-USA) and Trypanosomatid Culture Collection of the University
of São Paulo (TCC-USP) (Brazil) projects, and were obtained as previously described [34].
Obtained sequences were aligned using MUSCLE v3.8.31 [35] and visualized using Seaview
v.4.5.4 [36]. Inferred phylogenies were obtained by the maximum likelihood (ML) and parsimony
(P) methods using Randomized accelerated Maximum Likelihood (RAxML) v8.2.4-1 [37] and Tree
Analysis Using New Technology (TNT) v1.1 [38]. To infer ML phylogeny, the GTRGAMMA model was
used. Branch statistical supports were obtained using Bootstrap with 1000 replicates as implemented
in RAxML and TNT. Obtained phylogenetic trees were visualized using Figtree v1.4.3 [39].
2.7. TcPRODH and TcMDH Enzymatic Activities Assays
The enzymatic activities for both T. cruzi Proline Dehydrogenase (TcPRODH) and T. cruzi Malate
Dehydrogenase (TcMDH) were measured in cell-free homogenates from epimastigotes in exponential
and stationary phases (Figure 2). PRODH enzyme activity was measured by reducing a dye used as an
electron acceptor, dichlorophenolindophenol (DCICP) (Figure 2A) [40]. The reaction contained 11 mM
of 3-(N-morpholino) propanesulfonic acid (MOPS), 11 mM of MgCl2, 11% (v/v) glycerol, 0.26 mM of
phenazin methosulfate (PMS), and 56 µM of DCICP; pH 7.5 and 60 µm of L-proline was initiated by
the addition of the enzyme extract and the activity measured at optical density (OD) of 600 nm. malate
dehydrogenase (MDH) enzyme activity was measured by oxaloacetate (OAA) reduction (Figure 2B).
The reaction contained 100 mM of phosphate buffer, pH 7.5, 0.35 mM of OAA, and 0.12 mM of NADH,
and was initiated by the addition of the enzyme extract [41]. The activity was monitored by measuring
the absorbance (OD) at 340 nm.
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An unpaired t-student test was us d to nalyze the differences between groups using Perseus
v.1.5.1.6 [27]. p-value < 0.05 was considered statistically significant.
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3. Results and Discussion
3.1. Morphological and Molecular Characterization of T. cruzi in the Exponential and Stationary Phases
This study aimed at dissecting the molecular pathways activated in T. cruzi epimastigotes upon
transitioning from the exponential to the stationary phase. The morphology of T. cruzi epimastigotes
in the exponential and stationary phases present important differences. During the stationary phase,
the parasite shows a slender shape with an elongated cellular body and flagellum (Figure 1C). A longer
flagellum has been associated with limited glucose availability, which is a condition present during
the stationary phase [42]. Moreover, a longer flagellum increases the ability to adhere to hydrophobic
substrates and initiate the metacyclogenesis [43]. An increase in nucleotides, amino acids, and sugar
transporters could facilitate the parasite survival during the stationary phase. The nucleolus of
epimastigotes in the exponential phase are large, while in the stationary phase, they are reduced
with the nucleus dispersed [44,45]. These morphological changes are exacerbated in the metacyclic
trypomastigote, and have been associated with a reduced ribosomal protein content [46].
The following paragraphs will elucidate the protein-based molecular features of the T. cruzi in the
exponential and stationary phases.
3.2. Differential Protein Expression in the T. cruzi Exponential and Stationary Phases
In this study, we applied quantitative mass spectrometry-based proteomic analysis to identify and
quantify proteins present in the exponential and stationary phase of T. cruzi (Figure 1A). T. cruzi cells
were collected during the exponential (from two to four days) and stationary phase (from five to eight
days) (Figure 1B); then, they were lysed, and the extracted proteins were digested with trypsin. Tryptic
peptides were analyzed by large-scale mass spectrometry-based proteomics and bioinformatics, and
functional analyses were performed (Figure 1A).
A total of 3440 proteins were identified. Of these, 3421 proteins were identified with at least
one unique peptide, and 2720 proteins were identified with more than two peptides (Table S1).
In particular, 1675 and 1721 proteins were identified in the biological replicate 1 and 2 of the stationary
phase, and 2117 and 2509 proteins were identified in the biological replicate 1 and 2 of the exponential
growth phase (Table S1), respectively. Of the total proteins identified, 1712 proteins were annotated
as uncharacterized, corresponding to 50% of the total protein identified. These results confirm the
percentage of hypothetical and uncharacterized proteins annotated in the T. cruzi proteome [46]. A total
of 14,846 peptides were identified with an average of four peptides per protein. These results indicate
a high proteome coverage with a larger proportion of peptides identified in the exponential phase.
The identified proteins spanned a diverse molecular weight range from 8 kDa (Ubiquitin, putative,
Tc00.1047053447255.4) to 530 kDa (Uncharacterized protein, Tc00.1047053507083.109) (Table S1). A total
of 3091 proteins were quantified with a mean standard error of the mean of 10% for the stationary
phase and 12% for the exponential phase. The intrasample protein abundance was calculated using
the intensity-based absolute quantification (iBAQ) value [47]. In particular, normalized iBAQ values
were calculated for each protein in each biological replicate, and an average normalized iBAQ was
derived for each condition. The 100 proteins with the highest and the lowest iBAQ value were
analyzed (Figure 3A,B). Interestingly, there was a high overlap (74%) between the 10 proteins with the
highest abundance in the stationary and exponential phases, while low overlap (22%) was observed
for the lowest abundant (Figure 3C). Between the highest abundant proteins, there were histones,
heat shock proteins, tubulins, calpains, tryparedoxins, and metabolic enzymes. Proteins with the
lowest abundance in the stationary phase were uncharacterized DNA and RNA-binding proteins.
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(A) intensity-based absolute quantification (iBAQ) values for the top 100 most abundant and
(B) lowest abundant proteins identified in the stationary and exponential phases, H and L, respectively.
iBAQ values were derived from LC-MS/MS values using the MaxQuant computational platform.
(C) Normalized iBAQ values for the proteins identified and quantified in the exponential and stationary
phases. Normalized iBAQ values were obtained by dividing each value for the total iBAQ in each
biologic l replicate and av raging the two values. (D) Pearson c rrelation profile between the quantified
proteins identified in th two biological replicates of the exponential (Expo1 and Expo2) and stationary
phases (St1 and St2).
Relative protein abundance was assembled from the mass spectrometric signal of each
corresponding peptide, identified, and matched across the different technical and biological replicates.
High correlation was observed between the different biological replicates (0.98) and the different
conditions (0.96) (Figure 3D). Principal component analysis (PCA) using 1459 proteins quantified
in all of the bio ogical replicates and in all of the condit ons showed a clear separation between the
two growth phases, indicating a complete remodeli g of the T. cruzi proteome (Figure 4A). A total
of 290 proteins were statistically regulated in the two conditions (FDR < 0.05), with 131 and 159
upregulated in the exponential and stationary growth phases, respectively (Figure 4C). Proteins
upregulated in the exponential phase showed higher fold change compared to the ones upregulated in
the stationary phase. Some of the highest upregulated proteins in the exponential phase were ribosomal
proteins, while some of the highest upregulated proteins in the stationary phase were metabolic
enzymes, indicating a stage-specific modulation of biological processes (Table S2). Moreover, 197 and
25 protei s were uniquely detecte in all of the biological replicates in the xponential and stat onary
growth pha es, respectively (Figure 4B). It hould be noted that th identificati n in one condition does
not imply the absence of that protein, but it is related to the abundance below the limit of detection
and/or the presence of modified peptides (Table S3). This result is in apparent contrast with the
observations of Parodi-Tolice et al., who found that almost 50% of the two-dimensional electrophoresis
(2DE) spots were uniquely present in one stage [14]. However, our results are in agreement with the
study from de Godoy et al. which detected a large proportion of proteins shared between the different
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metacyclogenesis stages [15]. This difference could be due to the technology used for detecting protein
expression, 2DE versus shotgun, and more likely, to the presence of post-translational modifications
that could be associated to stage-specific unique protein spots. Indeed, in a recent report, Amorim et al.
have identified 260 phosphorylation events modulated during metacyclogenesis [18].
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Figure 4. antitative analysis of proteins identified in the T. cruzi expo ential and stationary
phases. (A) Principal component analysis (PCA) analysis of label-free quantification (LFQ) values
for the two biological replicates of exponential (Expo1 and Expo2) and stationary (St1 and St2)
phases. (B) Number of total, regulated and unique proteins identified. (C) Volcano plot (Log2
(Exponential)-Log2 (Stationary) vs. –Log10 (p-value)) of quantified proteins in the exponential and
stationary phases. Purple dots represent proteins upregulated in the exponential phase, while blue
dots represent proteins upregulated in the stationary phase.
The total and regulated proteins were mapped to gene ontology categories (Figure 5).
The overrepresented categories were calculated based on the total T. cruzi CL Brener proteome
(FDR ≤ 0.05). The regulated proteins presented higher enrichment in the ribos me, golgi,
endoplasmatic reticulum, chromosome, and nucleus compared to th total proteins that were enriched
mo e in the membrane and cytoplasm cellul r compartmen s (Figur 5A). These data suggest
the r gulation of proteins involved in different subcellular compartments associated t specific
biological functions. Th regulated proteins were enriched in metabolic processes, cell divi ion,
cell differentiation, and communication compared to the total proteins, which were enriched more in
cellular homeostasis, response to stimulus, and transport biological processes (Figure 5B). Moreover,
the molecular functions enriched in the regulated proteins were the antioxidant, structural, and
transporter activity along with DNA and RNA binding compared to the total proteins, highlighting
the regulation of specific molecular functions during the transitioning from the two growth phases
(Figure 5C). It should be noted that 50% of the proteins were classified as unannotated for their
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cellular components, biological processes, and molecular functions. This is in agreement with the large
percentage of uncharacterized proteins identified. The unannotated proteins are discussed below.
Moreover, gene ontology categories were mapped against the protein expression values (Figure 6).
Proteins associated to ribosome, nucleus, chromosome, cytosol, and cytoskeleton cellular components
were upregulated in the exponential phase (Figure 6A). These data can be associated with the high
expression of ribosomal proteins in the exponential phase. Indeed, 36 ribosomal proteins were
upregulated in the exponential phase, and one was uniquely identified in the stationary phase (Table 1).
Indeed, protein synthesis during growth phase transitioning is reduced as shown by the lower
incorporation of [35S]-methionine in T. cruzi epimastigotes entering the logarithmic growth phase [48].
The downregulation of protein synthesis during T. cruzi transitioning from the exponential to the
stationary phase supports the lower metabolic activity of the parasite during nutritional stress. On the
contrary, proteins associated with the endoplasmic reticulum were upregulated in the stationary phase
(Figure 6A, Table S2). Within the endoplasmic reticulum-associated proteins, calreticulin was found
overexpressed twofold in the stationary phase compared to the exponential phase. Calreticulin is a
ubiquitous calcium-binding chaperone involved in the correct folding of native glycoproteins. T. cruzi
calreticulin (TcCRT) is a 45 kDa protein that binds monoglucosylated glycans of proteins to assure their
proper folding, such as cruzipain [49]. Moreover, TcCRT is shuttled to the parasite surface interacting
with the complement system. This interaction inhibits the complement system activation, facilitating
the host immune system, and functioning as a molecular mimicry to invade the host cells increasing
T. cruzi infectivity [50]. In our study, two calreticulin proteins (Q4DDX3; Tc00.1047053509011.40
and Q4CPZ0; Tc00.1047053510685.10) were upregulated in the stationary growth phase (Table S2).
The upregulation of this protein could be related to its protective role against misfolded proteins
and/or its role in infectivity. More experiments are needed to determine the localization and role of
TcCRT during metacyclogenesis.
The biological processes upregulated in the exponential growth phase were cell division,
cell communication, cell organization, and biogenesis. On the contrary, cell differentiation and cellular
movement were upregulated in the stationary growth phase (Figure 6B). These results support the
phenotypical evidence of replicative exponential form and differentiating stationary form. Enzyme
regulator activity, DNA and RNA binding were upregulated in the proliferative phase, while the
molecular process upregulated in the quiescent phase was motor activity (Figure 6C).
3.3. Membrane Proteins Regulation during Growth Phase Transitioning
Half of the total and regulated proteins identified in this study contained more than one
transmembrane domain, indicating a remodeling of the membrane proteome (Figure 5D).
One of the membrane proteins regulated during transitioning from the exponential to the
stationary growth phase was amastin (Q4CVL1, Tc00.1047053509051.20), which was upregulated in the
stationary phase (Supplementary Table S2, Figure 7). The amastin gene family includes 20 kDa surface
membrane glycoproteins with a signal peptide, and four transmembrane domains with structural
similarity to claudin [51]. This gene family is present in several trypanosomatids such as Leishmania,
where α-, β-, γ-, and δ-amastin subfamilies are found [52], while in T. cruzi, the amastin gene family
contains the two genes for the β- and four genes for the δ-amastin subfamilies. Amastin genes are
highly expressed in the intracellular life stages of T. cruzi and Leishmania [53,54]. Interestingly, mRNA
expression of different amastin subfamilies in CL Brener, Y, G, and Sylvio X-10 strains showed an
upregulation in the amastigote form for the δ-amastins, while the β subfamilies were upregulated in
the epimastigote form [28]. In this study, we detected the upregulation of the amastin β1 subfamily
(Tc00.1047053509051.20) in the stationary growth phase compared to the exponential phase. Beside
this gene, another member of the amastin β1 subfamily (Tc00.1047053509965.390) and amastin β2
subfamily (Tc00.1047053511497.19) were identified in the total proteome. None of them fulfilled the
requirements to be selected for statistical analysis; however, Tc00.1047053511497.19 showed the same
trend as Tc00.1047053509051.20 with upregulation in the stationary growth phase (Figure 7A).
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These results are in apparent contrast with the mRNA results that showed upregulation of
β-amastins in the epimastigote form (Figure 7B). However, a proteomic analysis of T. cruzi during
metacyclogenesis showed the upregulation of members of β1-amastins (Tc00.1047053509051.20) in
the metacyclic trypomastigotes compared to epimastigotes [15]. These results highlight a specific
modulation of this gene family during metacyclogenesis and its potential involvement in parasite
infectivity. In L. braziliensis, amastin knockdown impaired intracellular parasite growth in vitro, and
did not cause infection in vivo [51]. These data point toward an important role of the amastin gene
family in parasite survival, growth, and infectivity. More studies are needed to elucidate the functional
role of amastins in T. cruzi biology.
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Table 1. Ribosomal proteins regulated during transitioning from the exponential to the stationary
growth phase. The exponential to stationary phase ratio is reported. Exp and St indicate proteins that
were uniquely identified in the exponential and stationary phase, respectively.
Proteins Name Exp/St
Q4E088 40S ribosomal protein S10 10.09
Q4E078 Ribosomal protein L24 6.33
Q4E3M0 40S ribosomal protein S21 4.69
Q4DZ31 60S ribosomal protein L18a 4.75
Q4D4L4 40S ribosomal protein S11 3.53
Q4DEK4 40S ribosomal protein S16 2.87
Q4D1T6 Ubiquitin/ribosomal protein S27a 2.91
Q4DJZ6 Ribosomal protein L15 OS 2.78
Q4DVM4 60S ribosomal protein L7 2.43
Q4DG45 60S ribosomal protein L26 2.28
Q4DVM5 60S ribosomal protein L7 2.21
Q4D5P4 40S ribosomal protein S4 2.25
Q4DI49 60S ribosomal protein L23a 2.22
Q4DTQ1 40S ribosomal protein S23 2.02
Q4DC23 60S ribosomal protein L17 1.93
Q4DPQ8 60S ribosomal protein L2 1.93
Q4CLU9 40S ribosomal protein S8 1.91
Q4CVQ4 60S acidic ribosomal protein P2 beta (H6.4) 1.81
Q4CQ63 40S ribosomal protein SA 1.81
Q4DW38 40S ribosomal protein S24 1.74
Q4E4R1 60S ribosomal protein L23 1.73
Q4DJY1 Ribosomal protein S19 1.68
Q4E3R2 60S ribosomal protein L7a 1.64
Q4DJX1 Ribosomal protein L3 1.66
Q4DZ41 40S ribosomal protein S3a-2 1.62
Q4DD50 60S ribosomal protein L10 1.62
Q4D6H7 Ribosomal protein S20 1.56
Q4E0N6 40S ribosomal protein S15a 1.50
Q4CTR5 40S ribosomal protein L14 1.50
Q4DGZ5 40S ribosomal protein S15 1.47
Q4DIZ9 40S ribosomal protein S2 1.41
Q4DIV9 60S ribosomal protein L6 1.40
Q4CU61 60S ribosomal protein L5 1.39
Q4D991 60S acidic ribosomal protein Exp
Q4DTK4 50S ribosomal protein L7Ae Exp
Q4DN72 60S ribosomal protein L34 Exp
Q4DMS9 Ribosomal protein L27 Exp
Q4CQG0 40S ribosomal protein S12 St
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membranes which creates a proton motif force (energy) that is utilized by secondary transporters
to transport ions and metabolites in and out of the cells [58]. On the other hand, mitochondrial
membrane-bound ATP/ADP carrier protein 1 and a putative ATP synthase F1 alpha subunit were
upregulated in the exponential growth phase. These enzymes are involved in mitochondrial proton
transport. The downregulation of ATP synthases and upregulation of ATPases in the stationary phase
(Table S2) are in accordance with the reduced intracellular ATP pool that is associated with starvation,
reduced glycolysis, and motility in the quiescent state in T. cruzi [59].
Two gene products were associated to Gim5a and upregulated during the exponential to stationary
phase transitioning. The first Gim5a protein (Q4E4Q2, Tc00.1047053508461.570) was upregulated in
the stationary phase (Supplementary Table S2). This protein has a predicted molecular weight of
26 kDa and contains two transmembrane domains and no signal peptide. The other Gim5a gene
product (Q4CR45, Tc00.1047053510669.49) was only found in the stationary phase. This protein has
a predicted molecular weight of 17 kDa and has one transmembrane domain. Both proteins contain
the Peroxisomal biogenesis factor 11 (PEX11) domain [60]. PEX proteins are involved in microbody
biogenesis and the import of matrix proteins [61–63]. In T. brucei, the three most abundant glycosomal
membrane proteins are PEX11 isoforms [64,65]. The TbPEX11 gene encodes for a 24-kDa glycosomal
membrane protein that is essential in trypanosomes. The modulation of this protein caused the
remodeling of glycosomal size and number in T. brucei, being vital for its survival. The other two
proteins are glycosomal integral membrane (GIM) proteins, GIM5A and GIM5B [66]. The depletion of
GIM5B is lethal for the bloodstream form of T. brucei, while the procyclic form is able to survive in the
same conditions, indicating a GIM5-dependency based on the life stage [67]. Moreover, Gim5 depletion
leads to changes in the morphology of glycosomes and mitochondria and the different expression of
ether-linked lipids [67]. Little is known about the function of the Gim5 protein in T. cruzi. Interestingly,
no Gim5b protein has been annotated in the T. cruzi proteome, while one protein was annotated in
the T. evansi and two in the T. grayi. The mRNA levels of the Gim5a protein show an upregulation in
the amastigote form after 48 h of infection compared to the epimastigote form of T. cruzi Y strain [29].
However, its role in modulating metabolic pathways and affecting glycosomal and mitochondria
morphology is still unknown. During transitioning from the exponential to the stationary phase, the
overexpression of the GIM5a protein in T. cruzi could be involved in the glycosomal integrity and
supply of metabolites and energy for parasite survival. More experiments are needed to elucidate the
role of this protein in T. cruzi.
Despite the morphological changes that T. cruzi undergoes when transitioning from the
exponential to the stationary growth phase, no differences have been detected in the expression
levels of actin and tubulin [68]. Indeed, Cevallos et al., using a polyclonal serum raised against a
44 kDa recombinant T. cruzi actin protein, observed no changes in actin expression in the two growth
phases, despite a lower level of actin mRNA that was more stable in the stationary phase compared to
the exponential phase [69]. This study confirmed previous findings since actin, actin-like, actin-related
proteins, and tubulins were not found to be differentially expressed during transitioning from the
exponential to the stationary phase (Table S2). Interestingly, 2DE highlighted differentially regulated
actin proteoforms in the epimastigote, amastigote, and trypomastigote forms, suggesting the regulation
of these structural proteins based on post-translational modifications [68].
Furthermore, we mapped the domains in the regulated proteins using the protein families (Pfam)
domain database (https://pfam.xfam.org/). A total of 560 domains were detected in 395 proteins.
The majority of the domains were associated to a single protein. However, the RNA recognition
domains (PF00076 and PF14259) were identified in 10 and nine regulated proteins, respectively,
confirming the regulation of proteins involved in RNA metabolism during transitioning from
the exponential to the stationary phase (Figure S1). Interestingly, the autophagy protein Apg6
(PF04111) domain was associated with eight regulated proteins. Proteins involved in the formation of
autophagosomes play an important role in the protein degradation process induced by starvation [70].
This domain was mapped to several uncharacterized proteins, which are discussed below.
Genes 2018, 9, 413 16 of 29
3.4. The Uncharacterized Proteome Modulated during Transitioning from Exponential to Stationary Growth Phase
To gain a deeper understanding of the differentially regulated uncharacterized proteins’ functions
during transitioning from the exponential to the stationary growth phase, we investigated their
domains using standalone RPS-BLAST search using the conserved protein domains present in CDD.
The uncharacterized proteins that were regulated and did not have: (1) primary sequence similarity to
any known protein, (2) any previously annotated domain and (3) a specific gene ontology category
classification, were analyzed by structural homology search. A total of 167 unique domains were
assigned to 119 regulated uncharacterized proteins (Table S4), while 86 uncharacterized proteins could
not be assigned to any known domain from CDD.
The most abundant domain represented in the uncharacterized upregulated proteins in the
stationary phase was the APG6 conserved protein domain structure (pfam0411) with 39 APG-related
domains belonging to four proteins (Q4DQS9, Q4CVE1, Q4CT11, and Q4CT56) compared to one APG
domain found in Q4DSZ0 upregulated in the exponential phase (Table S4). Of the 39 APG domains,
23 domains belonged to Q4CT56, which was uniquely identified in the stationary phase with two
unique peptides. Autophagy is an eukaryotic cellular response that degrades and recycles cytosolic
components, including aged organelles, aberrantly folded proteins, or protein aggregates through
lysosomal degradation [6]. Two ubiquitin-like conjugation systems, Atg12 and Atg8, are essential for
the formation of autophagosomes in mammalian and yeasts cells [71,72]. The Atg12 system forms
a 350-kDa complex (Atg12-Atg5-Atg16) in the cytosol that forms a pre-autophagosomal transient
membrane coat that drives the deformation of the sequestering membrane during vesicle formation [72].
In T. cruzi, the Atg8 conjugation system made up of Atg3, Atg4, Atg7, and Atg8 has been identified
in the parasite’s genome [73]. Further, Alvarez et al. demonstrated that autophagy is active in
all four stages of the parasite, and is upregulated in events of starvation and differentiation [73].
During metacyclogenesis induced by nutritional and thermal stress, it has been demonstrated that
autophagy is upregulated, and that the induction of autophagy promotes the metacyclogenesis of
T. cruzi [74]. Host cell autophagy also plays a role in the lysosomal-dependent T. cruzi entry into host
cells, as demonstrated by the presence of host cell autophagic protein LC3 in the vacuole containing
T. cruzi and the recruitment of autolysosomes to parasite entry sites [75]. Meanwhile, the parasites
autophagy process was shown to be upregulated in amastigotes after 72 h, when the intracellular
amastins are undergoing differentiation [75]. The upregulation of this domain in the epimastigote
stationary phase suggest the initial stages of autophagy induction during transitioning of T. cruzi.
This is in agreement with Vanrell et al. [74], who describe autophagy as a key process in the transitioning
of T. cruzi epimastigotes to metacyclic trypomastigotes.
The most abundant domain among the upregulated uncharacterized proteins in the exponential
phase detected in the two growth phases was the WD40 domain Gβ repeat (pfam00400) with 12 domain
hits belonging to four proteins (Q4DKP1, Q4DCC3, Q4DEL9, and Q4DCC3) (Table S4). Proteins
with the WD (tryptophan/aspartic acid) domain play diverse biological functions, including cell
division, gene transcription, transmembrane signaling, mRNA modification, apoptosis, cytoskeleton
assembly, and sulfur metabolism regulation [76,77]. In addition, proteins belonging to this
domain show unusual functional diversity considering their conserved sequence motif and tertiary
structures [77]. More studies are needed to define the function of this domain during T. cruzi growth
phase transitioning.
WD repeat proteins arose during the divergence of eukaryotes from prokaryotes or during early
eukaryote stages [77]. This is corroborated by the presence of this domain in trypanosomes belonging
to Euglenozoa, which is one of the first eukaryotes to diverge. T. cruzi is genetically highly diverse, and
is divided into six discrete typing units (DTUs) termed TcI-TcVI [78], which infect man, and Tcbat [79],
which is restricted to bats. Phylogenetic inferences based on the uncharacterized protein expressing
the WD domain, Q4DEL9, confirm the relationships between Schizotrypanum species, placing T. cruzi
DTUs clustering forming a monophyletic group and bat restricted trypanosomes T. dionisii and
T. erneyi positioned basally to the lineage formed by T. cruzi marinkellei and T. cruzi DTUs. T. cruzi
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isolates clustered forming three groups. Isolates from the same DTUs did not cluster to form a
monophyletic group; this has been noted in previous studies based on other molecular markers such as
SSU rRNA. The incongruence between the phylogenetic relationships among DTUs is explained by the
high conservation of this gene, showing low polymorphism levels to access inter-DTU phylogenetic
relationships. Moreover, TcII and TcIII ipolyphyletic clustering with TcV and TcVI is due the hybrid
nature of the DTUs TcV and TcVI.
3.5. Protein N-Terminal Acetylation in T. cruzi Epimastigote during Transitioning from Exponential to
Stationary Growth Phase
Protein acetylation is among the most common co-translational and/or post-translational
modifications of proteins [80]. The incorporation of acetyl (acyl) groups (-COCH3) from the
donor molecule acetyl-Coenzyme A (acCoA) to the α-amino group of protein N-terminal (termed
N-α/Nα /N-t acetylation) or to the ε-amino group of lysine residues (termed N-epsilon/Nε- or K-ε
acetylation) is catalyzed by N-terminal acetyltransferases (NATs) and lysine acetyltransferases (KATs),
respectively. N-α acetylation plays regulatory and functional roles, including DNA recognition, protein
stability, protein–protein interactions, and protection from proteolytic degradation by the action of
aminopeptidases, subcellular targeting, and protein folding [81]. K-ε acetylation functions in the
regulation of transcriptional activation, cell cycle progression, and DNA repair [82,83].
The N-terminal acetylation irreversibly adds an acetyl group to the N-α-amino group of a
polypeptide. It usually happens during translation when the first peptide emerges from the ribosome
tunnel with the acetylation of methionine. Alternatively, the second amino acid of the protein
can be Nt-acetylated after methionine removal by methionine aminopeptidases. This is called the
N-methionine excision mechanism, and the most common acetylated residues are Ser, Ala, Thr, Val,
and Pro. These residues are likely acetylated by a set of NATs that perform Nt-acetylation at specific
amino acid residues.
A total of 327 unique N-terminal acetylated peptide sequences mapping to 306 proteins were
detected. Within them, 66 were also N-terminally acetylated and deamidated in asparagine and
glutamine residues, and 50 were N-terminally acetylated and oxidated in methionine residue
(Figure 8A). Of these, 233 peptide sequences were only N-terminal acetylated, and considered for
further analyses (Table S5). The amino acids that were identified to be N-terminally acetylated were
methionine (77), serine (77), alanine (60), glycine (9), threonine (8), glutamic acid (1), and asparagine
(1) (Figure 8B).
A gene ontology analysis of acetylated proteins revealed that the majority of the acetylated
proteins were located mainly in the cytoplasm and intracellular organelles. The Kyoto Encyclopedia
of Genes and Genome (KEGG) pathways associated with the N-terminally acetylated proteins were
associated with RNA metabolism and proteasome (Figure 8D).
The total intensity of the acetylated peptides identified was higher in the exponential growth
phase compared to the stationary, although this value was not significant (Figure 8C). Interestingly,
37 N-terminally acetylated peptides were detected only in the exponential phase, and two N-terminally
acetylated peptides were detected only in the stationary phase, suggesting a high rate of protein
N-terminal acetylation during the exponential phase (Table 2). Fourteen proteins were identified
as N-terminally acetylated only in the exponential growth phase, while their protein abundance
was similar in the two conditions leveraging the issue of the mass spectrometric limit of detection
(Table 2). Within these proteins, we found acetyl-coenzyme A synthetase, adenylate kinase, and
aspartate carbamoyltransferase. Moreover, aspartyl and phenylalanyl-tRNA synthetases were uniquely
N-terminally acetylated in the exponential phase.
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The adenylate kinase enzyme (Q4E1S6, Tc00.1047053506855.180) was found downregulated
at the protein level in this study, and at the mRNA level in the exponential growth phase
compared to the stationary phase [28]. However, the acetylated N-terminal residue of this protein
was detected only in the exponential phase, suggesting a regulation of this protein through this
co-/post-translational modification.
Three adenine phosphoribosyltransferases (Q4DVM9, Q4DNZ4, and Q4DVM8) were acetylated.
The adenine phosphoribosyltransferase (Q4DNZ4; Tc00.1047053507519.140) was identified uniquely in
the stationary phase, while the other two proteins were equally expressed in the two growth phases.
Adenine phosphorybosyltransferase is involved in the purine salvage pathway, reutilizing purines and
purine analogues from the host and synthesizing AMP from adenine [84–86]. This enzyme has been
associated with benznidazol resistance in T. cruzi. Indeed, drug-resistant parasites have lower mRNA
and protein expression of adenine phosphoribosyltransferase [87]. The expression of this enzyme and
its regulation through acetylation might be an important drug target.
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Table 2. T. cruzi N-terminal acetylated peptides detected in one condition. Peptide sequences are reported. Nac_St and Nac_expo indicate the acetylated peptides in
the stationary and exponential phase, respectively. Prot_St and Prot_expo indicate the average protein expression in the stationary and exponential phase. * Proteins
quantified in two biological replicates in at least one condition were reported.
Peptide Proteins Name Nac_St Nac_exp Prot_St * Prot_expo *
AVVQTHCFNWMDHDGTR Q4DMP7 Uncharacterized protein 0 340,000,000 1,100,000,000 1,480,000,000
MMEGFYGVEVASGQQVKPK Q4D244 Nucleolar RNA-binding protein, putative 0 130,000, 000 559,000,000 758,000,000
MENLTVEEAR Q4DQY7 Acetyl-coenzyme A synthetase 0 107,000,000 1,710,000,000 2,450,000,000
ASVFYILDSK Q4DX10 Mu-adaptin 1, putative 0 14,581,000 277,000,000 194,000,000
ATAAVALAPTADAAGSVLEPLLDK Q4E342 Proteasome regulatory non-ATPase subunit 6, putative 0 56,185,000 340,000,000 599,000,000
STVEDFVLQALASTDAVESDK Q4DY45 Phenylalanyl-tRNA synthetase alpha chain, putative 0 58,198,000 320,000,000 290,000,000
SDPDKSNTAASQEDASGNVASK Q4CNC1 Aspartyl-tRNA synthetase, putative 0 58,968,500 745,000,000 688,000,000
SALTESLLDLHK Q4E3B2 Uncharacterized protein 0 514,565,00 71,460,000 151,000,000
TAFLDNKLEYLQK Q4E1S6 Adenylate kinase, putative 0 47,744,500 590,000,000 347,000,000
SLTLQSEQFQHIVR Q4E093 40S ribomal protein S18, putative 0 60,961,500 3,230,000,000 3,550,000,000
SVFGVDFGNLNSTVAITR Q4D673 Heat shock protein, putative (Fragment) 0 41,490,000 29,524,000 180,000,000
AALVHLPDPFVTLPFR Q4D509 Uncharacterized protein 0 26,870,850 217,000,000 206,000,000
MLELPPVASLK Q4D3W3 Aspartate carbamoyltransferase, putative 0 22,928,000 1,140,000,000 1,120,000,000
MIVLNGISEEQKK Q4DDB3 Uncharacterized protein 0 32,419,000 598,000,000 408,000,000
TDKKEEQQNTEEYDYDR Q4DTK4 50S ribomal protein L7Ae, putative 0 46,915,500 0 75,524,000
AEHLLEQLR Q4D4P8 Uncharacterized protein 0 127,000,000 0 123,000,000
MDLDAFLNKK Q4DUJ9 Uncharacterized protein 0 73,499,500 0 423,000,000
MFHGFPDVQIAPR Q4E3S5 Uncharacterized protein 0 59,240,000 0 128,000,000
GDVEQIVEKEETDIQANVLAIPTFEAMGLK Q4CMK2 ATP-dependent DEAD/H RNA helicase, putative (Fragment) 0 13,256,500 0 53,465,000
AELLTPK Q4E1W2 Uncharacterized protein 0 13,818,000 0 70,917,500
MFFEGACAK Q4CTR7 Malate dehydrogenase 0 26,409,500 0 193,000,000
MLNNELANLVDQQK Q4DM75 Protein translation factor SUI1 homolog, putative 0 121,000,000
SVAEGFLSHGEPCTR Q4DV00 Uncharacterized protein 0 81,500,500
MLHEIPLHDASASAAER Q4CX95 Uncharacterized protein 0 74,033,000
TAPSTTAASTAVPFLEVK Q4CQ45 Glutaminyl-tRNA synthetase, putative (Fragment) 0 50,153,500
SLEEVEPNFFTLSPDSPLR Q4DVM8 Adenine phphoribyltransferase, putative 0 48,383,000
AILPHGFIEAIHASPLR Q4DS12 Uncharacterized protein 0 39,947,500
METAPHNIQTER Q4DS85 Uncharacterized protein 0 16,433,000
SSDIIEHSFFFTPLER Q4DZY5 Cholinephphate cytidylyltransferase A, putative 0 25,039,000
SAFNPDAPAFIPTFLR Q4DNJ8 RNA guanylyltransferase, putative 0 45,679,500
MDFLHHVQGIVVLNELGGR Q4DEQ7 Coatomer zeta subunit, putative 0 51,783,000
MFDALSALVETASAK Q4D4V0 Uncharacterized protein 0 40,160,500
SGRPESVQGGNVESQSSNVSQGGR Q4E0M5 Retrotranspon hot spot (RHS) protein, putative (Fragment) 0 50,721,500
SHAGNVTNVYDEK Q4DXE3 Uncharacterized protein 0 30,738,000
AYNTPAWNEEFGVLK Q4DJ63 Uncharacterized protein 0 28,215,500
AALVHLPDQFVTLPFR Q4DP85 Uncharacterized protein 0 33,409,000
SDSTEQSVSKPETSK Q4CMM3 Uncharacterized protein 0 28,615,500
ADEVPMTKR Q4D6T8 Universal minicircle sequence binding protein (UMSBP), putative 37,170,000 0 4,410,000,000 4,790,000,000
SLEEVEPNFFILSPDSPLR Q4DNZ4 Adenine phphoribyltransferase, putative 117,000,000 0 186,000,000 0
Genes 2018, 9, 413 20 of 29
Two proteins were found to be N-terminally acetylated selectively in the stationary phase.
In particular, the universal minicircle sequence binding protein (UMSBP) was detected acetylated
uniquely in the stationary phase, while its protein expression was constant between the two growth
phases. The universal minicircle sequence binding protein binds the universal minicircle sequence that
constitutes the origin of the kinetoplast DNA replication [88]. Silencing of UMSBP in T. brucei inhibited
minicircle DNA replication and parasite growth arrest [89]. The mRNA transcript expression of UMSBP
in metacyclic trypomastigotes is drastically reduced compared to epimastigotes [28]. Moreover,
a decrease in UMSBP expression was detected in Leishmania donovani after inhibiting spermidine
synthesis through hypericin treatment [90]. In this study, we hypothesize that during the early
signaling events of metacyclogenesis, the N-terminal acetylation of UMSBP could lead to protein
degradation altering the replication of kinetoplastid DNA and arresting the parasite growth.
In higher eukaryotes, 6 N-acetyltransferase (NAT) complexes, NatA–NatF, have been described
with different substrate specificity and subunit composition [91]. These enzymes catalyze the addition
of an acetyl group to the primary amino group of the N-terminal protein residue using acetyl-CoA.
We explored the sequence homology of the human N-alpha-acetyltransferases using BLASTP against
T. cruzi NCBI non-redundant database. Human NatA (NAA10 (P41227), NAA11 (Q9BSU3), and NatB
(NAA20 (P61599) sequences showed sequence identities of 54%, 57%, and 52% respectively to
N-acetyltransferase complex ARD1 subunit from T. cruzi strain CL Brener. In yeast, ARD1 has
been proposed to function by controlling transcription [92]. NAA15 (Q9BXJ9) and NAA16 (Q6N069),
the human NatA auxiliary subunit proteins, had 28% protein sequence identity to N-acetyltransferase
subunit Nat1 from T. cruzi strain CL Brener. ARD1 and NAT1 form the ARD1-NAT1 complex that is
essential for N-terminal acetyltransferase enzyme activity [93]. Human N-α acetyltransferase NatC
catalytic subunit ((NAA30/ Q147X3) had a 45% and 27% sequence identity to a T. cruzi hypothetical
protein (Q4DGZ6) and a partial Nat complex ARD1 subunit (Q4D7K3), respectively. Sequence identity
of the human NatE catalytic subunit NAA50 (Q9GZZ1) and NatF catalytic subunit NAA60 (Q9H7X0)
to T. cruzi strain CL Brener shared a 35% and 29% sequence identity to an acetyltransferase (Q4DEI2)
and an hypothetical protein (Q4CRN8/Q4DGZ6). No NAT-related hit was found between human
NatD catalytic domain NAA40 (Q86UY6) and T. cruzi.
Initially, we screened the T. cruzi CL Brener genome, and found 18 sequences using the KEGG
database. These sequences contain N-terminal acetyltransferase-related domains, as determined
by the CDD database. Nine N-acetyltransferases were identified in our study (Table S6).
In particular, the N-acetyltransferase subunit Nat1 was detected with 10 peptides that were unable to
discriminate between the two gene products Tc00.1047053510301.80 and Tc00.1047053504163.110.
The exponential/stationary ratio was 1.1, indicating no regulation during phase transitioning.
The acetyltransferase putative (Tc00.1047053504867.40) was uniquely detected with two peptides
and with an exponential/stationary ratio of 1.7. Although there was a trend in the upregulation in
the exponential phase, this result was not statistically significant. Two RNA cytidine transferases
(Tc00.1047053511303.90 and Tc00.1047053509177.30) were determined to contain the Nat domain,
but no LFQ intensity was extracted. Two proteins were assigned as putative acetyltransferases
(Tc00.1047053511311.80 and Tc00.1047053508831.120), but were not statistically regulated between the
two conditions, leaving open the question about the regulation of these enzymes during transitioning
from exponential to stationary phase.
Another possibility of lower protein N-terminal acetylation in the stationary phase might
be related to the availability of acetyl-CoA. The expression of acetyl-CoA synthetase (Q4DQY7,
Tc00.1047053509331.30) was 1.43 times higher in the exponential phase compared to the stationary
(Table S2). A recent metabolomics analysis of T. cruzi epimastigotes in the exponential and stationary
phase did not detect the intracellular levels of acetyl-CoA [11]. However, the levels of isoleucine and
valine, branched amino acids involved in the biosynthesis of acetyl-CoA, were found downregulated
in the stationary phase. Moreover, the level of pyruvate was found to be lower in the stationary phase
compared to the exponential, supporting the hypothesis of a lower level of intracellular acetyl-CoA
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in the stationary phase. Cai L. and Tu B.P. measured the levels of acetyl-CoA in yeast cells cycling
from growth and quiescent phases. They found that acetyl-CoA levels decrease in the stationary
phase, leading to histones deacetylation and the upregulation of several genes related to starvation
and survival [4,5], suggesting an explanation for the high levels of N-terminal acetylated proteins in
the T. cruzi exponential phase.
To our knowledge, this is the first study that investigated the N-terminal protein acetylation in
T. cruzi during transitioning from exponential to stationary growth phases. Recently, Moretti et al.
compared the N-terminal and lysine acetylation of T. cruzi and T. brucei. Here, 64 proteins were
identified to be N-terminally acetylated in the epimastigote form of T. cruzi CL Brener with the majority
moieties located in methionine, serine, and alanine [94]. The N-terminally acetylated proteins were
associated to a diverse set of biological processes and compartments as shown in this study. It should
be noted that in both studies, N-terminally acetylated peptides were not enriched. More analysis is
needed in order to explore the N-terminal acetylome and clarify the enzymes involved in this process,
their substrate specificities, and the biological effects of this modification in protists.
Phylogenetic analysis of one of the Nat1 genes quantified in our analysis, Nat1 gene
(Q4D4R3/Tc00.1047053504163.110), was performed on T. cruzi strains and closely related trypanosome
strains. Our phylogenetic analysis based on the Nat1 gene showed that the separation of T. cruzi DTUs
from the closely related bat restricted T. c marinkellei, T. dionisii, and T. erneyi. The generalist T. rangeli
was used as the outgroup of Schizotrypanum lineage (Figure S3). In addition, parental genotypes
(TcII and TcIII) formed polyphyletic clustering with the hybrid DTUs (TcV and TcVI). However, this
gene could not resolve between TCI, TCII, and TCV, showing TCI to be more closely related to TcV
and TcII than to Tcbat. This indicates a non-conformity from the most common and well supported
T. cruzi phylogenies [95]. The high sequence conservation of the Nat1 gene among the T. cruzi DTUs
could explain the incongruence between the phylogenetic relationships among the DTUs, with low
polymorphism levels to access inter-DTU phylogenetic relationships. T. cruzi DTU clustering was
congruent for both ML and P using RAxML and TNT (data not shown).
3.6. Methionine Oxidation in T. cruzi during Transitioning from Exponential to Stationary Growth Phase
The redox status of T. cruzi cells has been identified as a molecular switch to guide the proliferative
to differentiation status of the parasite inside the triatomine vector. Indeed, Nogueira et al. suggested
that T. cruzi epimastigote cells require an oxidative environment to proliferate while the differentiation
process occurs in more reductive conditions [96]. The level of oxidized proteins in a biological system
is strictly regulated by a balance of reactive oxygen and nitrogen species concentration, the antioxidant
molecules concentration, and the activity of enzymes involved in the redox metabolism.
Initially, we focused on enzymes involved in the antioxidant molecules biosynthesis. Within the
highest abundant proteins that were uniquely found in the exponential phase using the iBAQ value,
there was cysthathionine beta-synthase (Q4DG21, Tc00.1047053508241.140) (Supplementary Table S1).
Cystathionine beta-synthase (CBS) is a key enzyme of the transsulfuration pathway [97]. T. cruzi
CBS mRNA is expressed in at least six independent isotypes with sequence microheterogeneity
from tandemly linked multicopy genes, and it forms a homotetramer. The CBS enzyme has serine
sulfhydrylase and cysteine synthase activities in vitro, and these activities are modulated in a
stage-specific manner [29]. In particular, both activities were eight to nine times higher in the
epimastigote than in the tissue culture-derived amastigote and trypomastigote. The mRNA level of
CBS in T. cruzi Y strain during the infection of human fibroblasts was higher in the epimastigote stage
than in the trypomastigote and amastigote, confirming the enzymatic activity results [29]. In our data,
CBS was found to be 1.6 times more abundant in the exponential phase compared to the stationary
phase, confirming the other observations (Table S2). These data could be explained based on the
presence of low oxygen tension conditions during the stationary phase. Indeed, it was found that
in yeast cells cultivated in aerobic conditions, CBS activity was three times higher [98]. Interestingly,
cystathionine, a CBS product, was not regulated between the exponential and the stationary phase
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while homocysteine, serine, and cysteine—CBS substrates—were significantly upregulated in the
stationary phase [11]. These results are apparently in disagreement between them; however, the lower
expression of CBS in the stationary phase could be a way to keep the thiol-containing amino acids
pool at higher concentrations in this growth phase. Moreover, we identified a 1.5-fold upregulation of
trypanothione synthetase (Q9GT49) in the exponential phase (Table S2). Trypanothione is the main
antioxidant molecule in the redox metabolism of trypanosomatids, and was found to be upregulated
in the exponential phase [11]. Based on these data, it is not possible to deduce the redox balance of the
two growth phases, since the cysteine and homocysteine are upregulated in the stationary phase, and
the trypanothione is upregulated in the exponential phase.
In order to evaluate the oxidation state of the T. cruzi proteins during growth phase transitioning,
we focused on the methionine-oxidized peptides. It should be noted that methionine oxidation
is a process induced by sample preparation in a common bottom–up proteomic experiment [99].
However, differential methionine oxidation can be observed in samples subjected to oxidative stress.
Due to that, we mapped the peptides oxidized in the methionine residues. First, 275 methionine
oxidized peptides were detected, of which 271 had a localization probability of more than 0.75.
From them, 134 methionine-oxidized peptides were present in the two biological replicates for at
least one biological condition, and were considered for further analyses (Table S7). The total intensity
of methionine-oxidized peptides showed a slight increase in the stationary phase compared to the
exponential phase; however, this difference was not significant (Figure S4). The distribution of
the Exp/St ratio of the methionine oxidized peptides showed a trend toward the stationary phase
(Figure S4). Interestingly, two peptide methionine sulfoxide reductases (Tc00.1047053509611.180 and
Tc00.1047053506945.160) were detected as significantly upregulated in the exponential phase.
More studies are needed to elucidate the oxidation state of different proteinogenic amino acids,
such as the cysteine, tryptophan, and tyrosine side chains, during T. cruzi growth phase transitioning
and their effect on the protein structure and function.
3.7. T. cruzi Malate Dehydrogenase and Proline Dehydrogenase are Regulated during Transitioning from
Exponential to Stationary Phase
Exponential growth phase T. cruzi epimastigotes use different carbon and energy sources
from those of the stationary growth phase. During the transition from exponential to stationary
growth phase, the complete exhaustion of glucose leads to a metabolic switch from a metabolism
based on glucose consumption to the usage of amino acids such as proline and histidine as energy
sources [11,100]. During the exponential growth phase, glucose is converted into pyruvate by the
glycolytic enzymes. Pyruvate can be fully oxidized in the mitochondrion through its conversion
into acetyl-CoA, which fuels the TCA cycle. During this process, electrons from acetyl-CoA are
transferred to oxidized nicotinamide adenine dinucleotide (NAD+) and flavin adenine dinucleotide
(FAD), forming the reduced NADH and FADH2, and are finally fed into the respiratory chain for
oxidative phosphorylation (OXPHOS). As the first steps of the glycolysis are compartmentalized in the
glycosome (a peroxysome-derived organelle), which is not able to exchange its pools of NAD+/NADH,
the produced NADH must be re-oxidized inside the glycosome to keep the glycolysis working.
As part of the reactions of the TCA cycle, the malate produced in the mitochondrion is oxidized to
oxaloacetate by the mitochondrial MDH. Oxaloacetate can be converted into aspartic acid (Asp) to
exit the mitochondrion through the malate/aspartate shuttle. Once in the cytoplasm, Asp can be
a substrate of the aspartate or the tyrosine aminotransferase, which are able to transfer the –NH2
group from Asp to an acceptor ketoacid (pyruvate, to form alanine, or alpha –ketoglutarate, to form
glutamate), releasing oxalacetate. Oxalacetate can freely diffuse into the glycosome, where it can be
reduced to malate by the glycosomal MDH, with the concomitant reoxidation of NADH to NAD+.
This complex cycle has both the mitochondrial and the glycosomal MDH as key players, and can
constitute a mechanism regulating the intra-glycosomal redox state in order to maintain the glycolytic
flux. As mentioned earlier, under glucose exhaustion, proline becomes one of the most relevant carbon
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and energy sources. Proline is well known as a “multi-functional metabolite” in T. cruzi. It is involved
in several essential aspects of the parasite’s life cycle, such as the differentiation from epimastigotes to
metacyclic trypomastigotes, and among intracellular stages, the host–cell invasion, and survival to
thermal and nutritional stress as well as to oxidative imbalance [20,59,101–103]. The catabolism
of Pro involves its oxidation into glutamate. This pathway is catalyzed by a FAD-dependent
proline dehydrogenase (PRODH) (Q4CVA1; Tc00.1047053506411.30) and a NAD(P)+-dependent
∆1-Pyrroline-5-Carboxylate Dehydrogenase (P5CDH) [20,104]. Both steps are able to fuel electrons
directly in the respiratory chain, which enables supporting ATP biosynthesis, even if the TCA cycle
is not functional. However, proline can be fully oxidized: after being oxidized into glutamate, it can
be deaminated to form the TCA intermediate alpha-ketoglutarate, which in turn can be converted
into malate [100]. As mentioned above, malate can be a substrate of the malate dehydrogenase
(MDH) to form oxaloacetate. Alternatively, if MDH is downregulated, it can be a substrate of the
malic enzyme. In this case, it is converted into pyruvate and later acetyl-CoA, which can be fully
oxidized in the TCA cycle. Noteworthy, if proline is being consumed instead of glucose, the need to
reoxidate glycosomal NADH is predictably diminished, as it is the need of MDH activity. Summarizing,
our work showed that two MDH isoforms (Q4CTR7 and Q4D4A1) were uniquely detected in the
exponential growth phase, which is consistent with the predominance of glycolysis, while PRODH
(Q4D4A1) is more expressed in the stationary phase, which is consistent with the predominance of
proline catabolism (Figure 9A). Moreover, we measured the activity of these two enzymes and found a
similar trend as reported for the protein expression (Figure 9B). The higher expression and activity of
∆1-Pyrroline-5-Carboxylate Dehydrogenase in the stationary phase was also confirmed by enzymatic
activity assay, showing a regulated proline metabolism during transitioning from exponential to
stationary phase (Figure 9, Figure S5) [11].
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4. Conclusions
The fine regulation of metabolic and signaling pathways during growth phase transitioning
of T. cruzi cells have been explored in this study. To our knowledge, this is the first study that
interrogated the T. cruzi proteome upon transitioning from the exponential/proliferative to the
stationary/differentiating phase in cell culture without externally induced stimuli. From more than
3000 proteins identified, 512 proteins were regulated at FDR <0.05. The findings reported in this
study support the hypothesis that during the transition from the exponential to the stationary phase,
T. cruzi activates a series of orchestrated multigenic/multiprotein events. Proteins involved in different
metabolic pathways such as glycolysis and proline catabolism and the remodeling of cell surface and
subcellular compartments are regulated during the two growth phases. These data complement the
literature on morphological and metabolic changes during growth phase transitioning, offering a
proteome-wide view on the key players in this process.
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